Metagenome Analysis of Gut Microbiota in CC Patients
NCT02395484 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2015-05-04
Summary
Constipation is a heterogeneous and multifactorial disease, influenced by a number of different genetic and environmental factors. By applying the standard two-stage GWAS strategy to design and carry out a metagenome-wide association study (MGWAS) to find the relationship between gut microbiota and constipation, to identify disease-associated metagenomic markers.
Conditions
Sponsors & Collaborators
-
Jinling Hospital, China
lead OTHER
Principal Investigators
-
Chao Ding, MD · Department of Generay Surgery, Jinling hospital
-
Hongliang Tian, PhD · Department of Generay Surgery, Jinling hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-06-30
Countries
- China
Study Locations
More Related Trials
-
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
NCT06801184 ·Status: RECRUITING
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.
NCT06208930 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Fecal Microbiota Transplantation
NCT04706611 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation
NCT05803993 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT03613545 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Gut Microbiota and Stool Frequency
NCT03153059 ·Status: COMPLETED
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Mitochondrial and Microbiota Relationship
NCT03213067 ·Status: COMPLETED
-
Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease
NCT02142101 ·Status: COMPLETED
-
Interactions Between Diet, Intestinal Microbiota and Metabolomics
NCT03475368 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiota in Chronic GI Diseases
NCT06532110 ·Status: RECRUITING
-
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NCT05803980 ·Status: RECRUITING ·Phase: NA
-
Probiotics and Gut Health
NCT01874301 ·Status: COMPLETED ·Phase: NA
-
Anorectal Manometry of Patients With Constipation Predominant IBS
NCT05921383 ·Status: NOT_YET_RECRUITING
-
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome
NCT01028898 ·Status: UNKNOWN
-
Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease
NCT05366335 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)
NCT01717404 ·Status: COMPLETED ·Phase: PHASE1
-
Dynamic Changes of Gut Microbiota in UC After FMT
NCT03949257 ·Status: UNKNOWN ·Phase: NA
-
IBS-C Questionnaire Study
NCT04968652 ·Status: COMPLETED
-
Human Intestinal Microbiota in Obesity and Nutritional Transition
NCT01314690 ·Status: COMPLETED ·Phase: NA
-
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
NCT03125564 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiome in Inflammatory Bowel Disease
NCT03589183 ·Status: RECRUITING
-
Brain-Gut-Microbiota Interaction in IBS
NCT04296552 ·Status: UNKNOWN ·Phase: NA